(Q41224253)

28 September 2017

1 reference

title

Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose (English)

1 reference

positron emission tomography

28 September 2017

main subject

1 reference

P Rigo

1

1 reference

28 September 2017

P Paulus

2

1 reference

28 September 2017

B J Kaschten

3

1 reference

28 September 2017

R Hustinx

4

1 reference

28 September 2017

T Bury

5

1 reference

28 September 2017

G Jerusalem

6

1 reference

28 September 2017

T Benoit

7

1 reference

28 September 2017

J Foidart-Willems

8

1 reference

28 September 2017

publication date

1 December 1996

1 reference

28 September 2017

number of pages

34

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

28 September 2017

volume

23

1 reference

28 September 2017

issue

12

1 reference

28 September 2017

page(s)

1641-1674

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01249629

28 September 2017

exact match

0 references

cites work

4-Borono-2-[18F]fluoro-d,l-phenylalanine: a possible tracer for melanoma diagnosis with PET

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Head and neck cancer: effect of food ingestion on uptake of C-11 methionine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Preoperative staging of non-small-cell carcinoma of the lung: imaging methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Risk of pneumothorax in CT-guided transthoracic needle aspiration biopsy of the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Hepatic metastases: basic principles and implications for radiologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Breast cancer: PET imaging of estrogen receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

New methods for imaging the breast: techniques, findings, and potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Hanson lecture. Adrenal imaging: current status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Positron emission tomography applied in the study of pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

PET evaluation of soft-tissue masses with fluorine-18 fluoro-2-deoxy-D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Cerebral glioma: evaluation with methionine PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Brain metastases from non-central nervous system tumors: evaluation with PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Prediction of survival in glioma patients by means of positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Barbiturates reduce human cerebral glucose metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Glucose uptake by gliomas after treatment. A positron emission tomographic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01249629

Functional imaging of head and neck tumors using positron emission tomography.

21 January 2018

1 reference

12 December 2020

Recurrent rectal cancer and scar: differentiation with PET and MR imaging

1 reference

12 December 2020

Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation

1 reference

12 December 2020

Positron emission tomography and computed tomography in differential diagnosis between recurrent or residual glioma and treatment-induced brain lesions.

1 reference

12 December 2020

High L-methyl-[11C]methionine uptake in brain abscess: a PET study

1 reference

12 December 2020

Application of whole-body positron emission tomography in the imaging of esophageal cancer: Report of a case

1 reference

12 December 2020

Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy

1 reference

12 December 2020

On the Origin of Cancer Cells

1 reference

12 December 2020

Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy.

1 reference

12 December 2020

Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma

1 reference

12 December 2020

Detecting recurrent or residual lung cancer with FDG-PET.

1 reference

12 December 2020

Dynamic study of supratentorial gliomas with L-methyl-11C-methionine and positron emission tomography.

1 reference

12 December 2020

Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer

1 reference

12 December 2020

Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG

1 reference

12 December 2020

Physicochemical Properties and Isoenzyme Composition of Hexokinase From Normal and Malignant Human Tissues

1 reference

12 December 2020

Mediastinal staging of non-small-cell lung cancer with positron emission tomography

1 reference

12 December 2020

Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumor. Evidence for an outer mitochondrial membrane location.

1 reference

12 December 2020

Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms

1 reference

12 December 2020

Performance characteristics of a whole-body PET scanner

1 reference

12 December 2020

Imaging metastatic testicular germ cell tumours with 18FDG positron emission tomography: prospects for detection and management

1 reference

12 December 2020

Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET

1 reference

12 December 2020

[Positron emission tomography in the evaluation of intrathoracic lymphatic extension of non-small cell bronchial cancer. A preliminary study of 30 patients]

1 reference

12 December 2020

Over-expression of facilitative glucose transporter genes in human cancer.

1 reference

12 December 2020

Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapy

1 reference

12 December 2020

In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET

1 reference

12 December 2020

FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma.

1 reference

12 December 2020

Stereotaxic biopsy and positron emission tomography correlation of cerebral gliomas

1 reference

12 December 2020

Effects of radiotherapy determined by 11C-methyl-L-methionine positron emission tomography in patients with primary cerebral malignant lymphoma

1 reference

12 December 2020

Dynamic study of methionine uptake in glioma using positron emission tomography

1 reference

12 December 2020

Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG

1 reference

12 December 2020

Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose

1 reference

12 December 2020

Proteins antigenically related to the human erythrocyte glucose transporter in normal and Rous sarcoma virus-transformed chicken embryo fibroblasts

1 reference

12 December 2020

Positron emission tomography for preoperative staging of colorectal carcinoma

1 reference

12 December 2020

Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial

1 reference

12 December 2020

Evaluation of pancreatic tumors with positron emission tomography and F-18 fluorodeoxyglucose: comparison with CT and US

1 reference

12 December 2020

FDG-PET for predicting the prognosis of malignant lymphoma

1 reference

12 December 2020

[18F]fluorodeoxyglucose scintigraphy in diagnosis and follow up of treatment in advanced breast cancer

1 reference

12 December 2020

Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity

1 reference

12 December 2020

FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS.

1 reference

12 December 2020

Distribution of the glucose transporters in human brain tumors

1 reference

12 December 2020

Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy

1 reference

12 December 2020

COMPARATIVE BIOCHEMISTRY HEPATOMAS. IV. ISOTOPE STUDIES OF GLUCOSE AND FRUCTOSE METABOLISM IN LIVER TUMORS OF DIFFERENT GROWTH RATES

1 reference

12 December 2020

Enhanced FDG-PET tumor imaging with correlation-coefficient filtered influx-constant images

1 reference

12 December 2020

Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67

1 reference

12 December 2020

Positron emission tomography diagnosis of pulmonary metastases in osteogenic sarcoma

1 reference

12 December 2020

Detection of breast cancer in women after augmentation mammoplasty using fluorine-18-fluorodeoxyglucose-PET

1 reference

12 December 2020

The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man

1 reference

12 December 2020

Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines.

1 reference

12 December 2020

Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays.

1 reference

12 December 2020

Analysis of 2-carbon-11-thymidine blood metabolites in PET imaging

1 reference

12 December 2020

In vivo effects of insulin on tumor and skeletal muscle glucose metabolism in patients with lymphoma

1 reference

12 December 2020

Increased accumulation of 2-deoxy-2-[18F]Fluoro-D-glucose in liver metastases from colon carcinoma

1 reference

12 December 2020

Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study

1 reference

12 December 2020

Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors

1 reference

12 December 2020

Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?

1 reference

12 December 2020

High [18F]FDG uptake in primary cerebral lymphoma: a PET study

1 reference

12 December 2020

Positron emission tomography (PET) in the evaluation of tumor proliferation and follow-up of therapy in ear, nose and throat tumors

1 reference

12 December 2020

Noninvasive grading of musculoskeletal tumors using PET

1 reference

12 December 2020

Positron emission tomographic evaluations in the diagnosis and therapy of multifocal glioblastoma. Report of a pediatric case

1 reference

12 December 2020

Assessment of radiotherapeutic effects on experimental tumors using 18F-2-fluoro-2-deoxy-D-glucose

1 reference

12 December 2020

The Application of Positron Emission Tomographie Imaging With Fluorodeoxyglucose to the Evaluation of Breast Disease

1 reference

12 December 2020

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation

1 reference

12 December 2020

The promise FDG in diagnosis and surveillance of head and neck cancer

1 reference

12 December 2020

Rapid and sensitive response of carbon-11-L-methionine tumor uptake to irradiation

1 reference

12 December 2020

Experience with positron emission tomography (PET) scans in patients with ovarian cancer

1 reference

12 December 2020

Recent incidence trends for breast cancer in women and the relevance of early detection: an update

1 reference

12 December 2020

Computed tomography of metastatic cervical lymph nodes. A clinical, computed tomographic, pathologic correlative study

1 reference

12 December 2020

PET with fluorine-18 deoxyglucose for pancreatic disease

1 reference

12 December 2020

Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer

1 reference

12 December 2020

Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG)

1 reference

12 December 2020

Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment

1 reference

12 December 2020

The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography

1 reference

12 December 2020

Pulmonary studies using positron emission tomography

1 reference

12 December 2020

Positron emission tomography with ([11C]methyl)-L-methionine, [11C]D-glucose, and [68Ga]EDTA in supratentorial tumors.

1 reference

12 December 2020

FDG-PET in the selection of brain lesions for biopsy.

1 reference

12 December 2020

The ECAT EXACT HR: performance of a new high resolution positron scanner.

1 reference

12 December 2020

Assessment of pancreatic blood flow with positron emission tomography and oxygen-15 water

1 reference

12 December 2020

Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas

1 reference

12 December 2020

Evaluation of emission-transmission registration in thoracic PET.

1 reference

12 December 2020

Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI

1 reference

12 December 2020

Transport of sugars in tumor cell membranes

1 reference

12 December 2020

Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription.

1 reference

12 December 2020

Small hepatocellular carcinomas: two-phase dynamic incremental CT in detection and evaluation

1 reference

12 December 2020

Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose

1 reference

12 December 2020

Influence of the blood glucose concentration on FDG uptake in cancer--a PET study.

1 reference

12 December 2020

Chemotherapeutic Management of Head and Neck Malignancies With Positron Emission Tomography

1 reference

12 December 2020

Characterization of chest masses by FDG positron emission tomography

1 reference

12 December 2020

The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients

1 reference

12 December 2020

Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas

1 reference

12 December 2020

The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

1 reference

12 December 2020

Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography

1 reference

12 December 2020

FDG-PET in oncology: there's more to it than looking at pictures

1 reference

12 December 2020

Positron emission tomography in the evaluation of laryngeal carcinoma

1 reference

12 December 2020

Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities

1 reference

12 December 2020

Positron emission tomography and ultrasonography. A comparative retrospective study assessing the diagnostic validity in lymph node metastases of malignant melanoma

1 reference

12 December 2020

Elevation of glucose transporter, c-myc, and transin RNA levels by Ha-rasT24 is independent of its effect on the cell cycle

1 reference

12 December 2020

PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome

1 reference

12 December 2020

Contribution of magnetic resonance spectroscopic imaging and L-[1-11C]tyrosine positron emission tomography to localization of cerebral gliomas for biopsy

1 reference

12 December 2020

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET

1 reference

12 December 2020

Krukenberg Tumor and Lung Metastases From Colon Carcinoma Diagnosed With F-18 FDG PET

1 reference

12 December 2020

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.

1 reference

12 December 2020

Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG.

1 reference

12 December 2020

Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors

1 reference

12 December 2020

Pet-FDG imaging in the clinical evaluation of head and neck cancer.

1 reference

12 December 2020

Clinical positron emission tomography for brain tumors: comparison of fludeoxyglucose F 18 and L-methyl-11C-methionine.

1 reference

12 December 2020

Fluorine-18 fluorodeoxyglucose positron emission tomography in the follow-up of differentiated thyroid cancer

1 reference

12 December 2020

Depressed cerebellar glucose metabolism in supratentorial tumors.

1 reference

12 December 2020

Evaluation of the solitary pulmonary nodule by positron emission tomography imaging

1 reference

12 December 2020

PET quantitation: blessing and curse

1 reference

12 December 2020

Clinical value of PET with 18F-fluorodeoxyglucose and L-methyl-11C-methionine for diagnosis of recurrent brain tumor and radiation injury.

1 reference

12 December 2020

Validation of postinjection transmission measurements for attenuation correction in neurological FDG-PET studies.

1 reference

12 December 2020

Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy

1 reference

12 December 2020

[18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I]

1 reference

12 December 2020

Clinical applications of positron emission tomography in cancer: the good, the bad and the ugly

1 reference

12 December 2020

A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection

1 reference

12 December 2020

Grading liposarcomas with PET using [18F]FDG

1 reference

12 December 2020

2-(fluorine-18)-fluoro-2-deoxy-D-glucose PET in detection of pancreatic cancer: value of quantitative image interpretation

1 reference

12 December 2020

Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation

1 reference

12 December 2020

[18F]fluorodeoxyglucose uptake in tumors: kinetic vs. steady-state methods with reference to plasma insulin

1 reference

12 December 2020

Monitoring liver tumor therapy with [18F]FDG positron emission tomography

1 reference

12 December 2020

Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node.

1 reference

12 December 2020

Metabolic imaging of human extremity musculoskeletal tumors by PET.

1 reference

12 December 2020

Recurrent tumor vs radiation effects after gamma knife radiosurgery of intracerebral metastases: diagnosis with PET-FDG.

1 reference

12 December 2020

Metabolic trapping as a principle of oradiopharmaceutical design: some factors resposible for the biodistribution of [18F] 2-deoxy-2-fluoro-D-glucose

1 reference

12 December 2020

Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma

1 reference

12 December 2020

Serial FDG-PET studies in the prediction of survival in patients with primary brain tumors

1 reference

12 December 2020

Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT

1 reference

12 December 2020

Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation

1 reference

12 December 2020

Identification of two enhancer elements in the gene encoding the type 1 glucose transporter from the mouse which are responsive to serum, growth factor, and oncogenes

1 reference

12 December 2020

Continuous-slice PENN-PET: a positron tomograph with volume imaging capability

1 reference

12 December 2020

Scar or recurrent rectal cancer. Positron emission tomography is more helpful for diagnosis than immunoscintigraphy

1 reference

12 December 2020

Degradation and biosynthesis of the glucose transporter protein in chicken embryo fibroblasts transformed by the src oncogene

1 reference

12 December 2020

Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography

1 reference

12 December 2020

Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool

1 reference

12 December 2020

The role of positron emission tomography in the detection of pancreatic disease

1 reference

12 December 2020

PET-FDG imaging and transthoracic needle lung aspiration biopsy in evaluation of pulmonary lesions. A comparative risk-benefit analysis

1 reference

12 December 2020

New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose

1 reference

12 December 2020

Positron emission tomographic imaging of the head and neck.

1 reference

12 December 2020

Use of positron emission tomography in oncology

1 reference

12 December 2020

The applications of PET in clinical oncology

1 reference

12 December 2020

CT-pathologic correlation of axillary lymph nodes in breast carcinoma

1 reference

12 December 2020

FDG-PET screening for cerebral metastases in patients with suspected malignancy.

1 reference

12 December 2020

Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma

1 reference

12 December 2020

Imaging of colorectal carcinoma

1 reference

12 December 2020

Value of fluorine-18-fluorodeoxyglucose and thallium-201 in the detection of pancreatic cancer

1 reference

12 December 2020

Potential role of FDG-PET imaging in understanding tumor-host interaction.

1 reference

12 December 2020

Comparison of thallium-201 and F-18 FDG SPECT uptake in squamous cell carcinoma of the head and neck

1 reference

12 December 2020

Role of positron emission tomography scanning in evaluating gastrointestinal neoplasms

1 reference

12 December 2020

Staging non-small cell lung cancer by whole-body positron emission tomographic imaging

1 reference

12 December 2020

Positron emission tomography of thyroid masses

1 reference

12 December 2020

PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy

1 reference

12 December 2020

Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography

1 reference

12 December 2020

Positron emission tomography and breast masses: comparison with clinical, mammographic, and pathological findings

1 reference

12 December 2020

Imaging of breast cancer with [18F]fluorodeoxyglucose and positron emission tomography

1 reference

12 December 2020

Comparison of fluorine-18-2-fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma

1 reference

12 December 2020

Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors

1 reference

12 December 2020

Cervical lymph node metastasis of thyroid papillary carcinoma imaged with fluorine-18-FDG, technetium-99m-pertechnetate and iodine-131-sodium iodide

1 reference

12 December 2020

Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography

1 reference

12 December 2020

Somatostatin receptor scintigraphy in malignant lymphoma: first results and comparison with glucose metabolism measured by positron-emission tomography

1 reference

12 December 2020

Local recurrence after sphincter-saving resection for rectal and rectosigmoid carcinoma. Value of various diagnostic methods

1 reference

12 December 2020

Predicting malignancy grade with PET in non-Hodgkin's lymphoma

1 reference

12 December 2020

Transformation stimulates glucose transporter gene expression in the absence of protein kinase C

1 reference

12 December 2020

Proceedings of a National Cancer Institute workshop: PET in oncology--a clinical research agenda

1 reference

12 December 2020

Clinical assessment of therapeutic effects on cancer using 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography: preliminary study of lung cancer

1 reference

12 December 2020

Clinical value of whole-body positron emission tomography with [18F]fluorodeoxyglucose in recurrent colorectal cancer

1 reference

12 December 2020

Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy

1 reference

12 December 2020

Therapy monitoring of presacral recurrences after high-dose irradiation: value of PET, CT, CEA and pain score

1 reference

12 December 2020

[Analysis of glucose metabolism in patients with esophageal cancer by PET: estimation of hexokinase activity in the tumor and usefulness for clinical assessment using 18F-fluorodeoxyglucose]

1 reference

12 December 2020

Clinical value of positron emission tomography (PET) in oncologic questions: results of an interdisciplinary consensus conference. Schirmerreschaft der Deutschen Gesellschaft for Nuklearmedizin

1 reference

12 December 2020

Growth factors rapidly induce expression of the glucose transporter gene

1 reference

12 December 2020

Positron emission tomography of glucose metabolism in breast cancer. Potential for tumor detection, staging, and evaluation of chemotherapy

1 reference

12 December 2020

Positron emission tomography: 2-deoxy-2-[18F]-fluoro-D-glucose uptake in locally advanced breast cancers

1 reference

12 December 2020

Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma

1 reference

12 December 2020

Primary hyperparathyroidism: preoperative parathyroid imaging with regional body FDG PET

1 reference

12 December 2020

Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography

1 reference

12 December 2020

Neuroimaging of juvenile pilocytic astrocytomas: an enigma

1 reference

12 December 2020

Cancer statistics, 1993

1 reference

12 December 2020

[Validity of positron emission tomography (PET) using 2-deoxy-2-[18F]fluoro-D-glucose (FDG) in patients with renal cell carcinoma (preliminary report)]

1 reference

12 December 2020

Use of positron emission tomography (PET) in stereotactic conditions for brain biopsy

1 reference

12 December 2020

Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers

1 reference

12 December 2020

Early treatment response in malignant lymphoma, as determined by planar fluorine-18-fluorodeoxyglucose scintigraphy

1 reference

12 December 2020

Positron emission tomography of pituitary macroadenomas: hormone production and effects of therapies.

1 reference

12 December 2020

Clinical PET: its time has come.

1 reference

12 December 2020

Role of computed tomography in the staging of primary melanoma

1 reference

12 December 2020

Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids

1 reference

12 December 2020

Positron-emission tomographic scanning of primary and metastatic breast carcinoma with the radiolabeled glucose analogue 2-deoxy-2-[18F]fluoro-D-glucose

1 reference

12 December 2020

Evaluation of treatment response to radiotherapy in head and neck cancer with fluorine-18 fluorodeoxyglucose.

1 reference

12 December 2020

Assessment of 21-[18F]fluoro-16 alpha-ethyl-19-norprogesterone as a positron-emitting radiopharmaceutical for the detection of progestin receptors in human breast carcinomas

1 reference

12 December 2020

Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes.

1 reference

12 December 2020

Quantitative metabolic PET imaging of a plasma cell granuloma

1 reference

12 December 2020

Quantification of glucose utilization in liver metastases: parametric imaging of FDG uptake with PET

1 reference

12 December 2020

Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose

1 reference

12 December 2020

Positron emission tomography with 11C-methionine and computed tomography of intracranial tumours compared with histopathologic examination of multiple biopsies.

1 reference

12 December 2020

Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings

1 reference

12 December 2020

Discrepancies in brain tumor extent as shown by computed tomography and positron emission tomography using [68Ga]EDTA, [11C]glucose, and [11C]methionine.

1 reference

12 December 2020

Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma.

1 reference

12 December 2020

Clinical and experimental imaging of breast cancer metastases in the spine.

1 reference

12 December 2020

Carbon-11-methionine and fluorine-18-FDG PET study in brain hematoma.

1 reference

12 December 2020

Positron imaging feasibility studies: selective tumor concentration of 3H-thymidine, 3H-uridine, and 14C-2-deoxyglucose

1 reference

12 December 2020

Diagnosis of pancreatic cancer by 2[18F]-fluoro-2-deoxy-D-glucose positron emission tomography

1 reference

12 December 2020

Positron emission tomography for the evaluation of pancreatic disease

1 reference

12 December 2020

Determination of malignancy of thyroid nodules with positron emission tomography

1 reference

12 December 2020

Imaging of head and neck tumors with positron emission tomography and [11C]methionine

1 reference

12 December 2020

Delayed radiation necrosis of brain evaluated positron emission tomography

1 reference

12 December 2020

Metabolic studies with L-[1-14C]tyrosine for the investigation of a kinetic model to measure protein synthesis rates with PET.

1 reference

12 December 2020

Use of 2-[F-18]-fluoro-2-deoxy-D-glucose PET to locate parathyroid adenomas in primary hyperparathyroidism

1 reference

12 December 2020

Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer

1 reference

12 December 2020

Glucose consumption in recurrent gliomas

1 reference

12 December 2020

Singles transmission in volume-imaging PET with a 137Cs source

1 reference

12 December 2020

Superimposition of PET images using 18F-fluorodeoxyglucose with magnetic resonance images in patients with pancreatic carcinoma

1 reference

12 December 2020

Pancreatic neuroendocrine tumors: diagnosis with PET

1 reference

12 December 2020

SUV: standard uptake or silly useless value?

1 reference

12 December 2020

Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer

1 reference

12 December 2020

Pancreatic adenocarcinoma: CT versus MR imaging in the evaluation of resectability--report of the Radiology Diagnostic Oncology Group

1 reference

12 December 2020

Ringlike uptake of [18F]FDG in brain abscess: a PET study

1 reference

12 December 2020

Pancreatic tumors: imaging with PET

1 reference

12 December 2020

Intermodality, retrospective image registration in the thorax.

1 reference

12 December 2020

Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake.

1 reference

12 December 2020

Salivary gland tumors: pretherapy evaluation with PET

1 reference

12 December 2020

[11C]L-methionine uptake in gliomas.

1 reference

12 December 2020

The need to reexamine axillary lymph node dissection in invasive breast cancer

1 reference

12 December 2020

18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy

1 reference

12 December 2020

Uptake of carbon-11-methionine and fluorodeoxyglucose in non-Hodgkin's lymphoma: a PET study

1 reference

12 December 2020

Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging

1 reference

12 December 2020

Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose.

1 reference

12 December 2020

PET as a tool in the clinical evaluation of pituitary adenomas

1 reference

12 December 2020

Metabolic and hemodynamic evaluation of gliomas using positron emission tomography.

1 reference

12 December 2020

In vivo metabolism of childhood posterior fossa tumors and primitive neuroectodermal tumors before and after treatment

1 reference

12 December 2020

Imaging of renal cancer using positron emission tomography with 2-deoxy-2-(18F)-fluoro-D-glucose: pilot animal and human studies

1 reference

12 December 2020

Positron emission tomography with fluorine-18-fluorodeoxyglucose for the evaluation of therapeutic isolated regional limb perfusion in a patient with soft-tissue sarcoma

1 reference

12 December 2020

Recurrent colorectal carcinoma: evaluation with barium enema examination and CT

1 reference

12 December 2020

Early and late responses to induction of rasT24 expression in Rat-1 cells.

1 reference

12 December 2020

F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer

1 reference

12 December 2020

Satellite PET and lung cancer: a prospective study in surgical patients

1 reference

12 December 2020

In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-11C]-tyrosine and PET

1 reference

12 December 2020

The cellular response to induction of the p21 c-Ha-ras oncoprotein includes stimulation of jun gene expression

1 reference

12 December 2020

18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography

1 reference

12 December 2020

Positron emission tomography-guided stereotactic brain biopsy.

1 reference

12 December 2020

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method

1 reference

12 December 2020

A modeling method to improve quantitation of fluorodeoxyglucose uptake in heterogeneous tumor tissue

1 reference

12 December 2020

Increased glucose metabolism in untreated non-Hodgkin's lymphoma: a study with positron emission tomography and fluorine-18-fluorodeoxyglucose

1 reference

12 December 2020

Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose

1 reference

12 December 2020

Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.

1 reference

12 December 2020

Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The Members of the PET-Lung Tumor Study Group

1 reference

12 December 2020

Effect of moderate level x-radiation to brain on cerebral glucose utilization

1 reference

12 December 2020

PET-fluorodeoxyglucose of cranial and spinal neuromas

1 reference

12 December 2020

Pre-operative staging of colorectal carcinoma using positron emission tomography

1 reference

12 December 2020

The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis

1 reference

12 December 2020

Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry

1 reference

12 December 2020

Indium-111 OncoScint CR/OV and F-18 FDG in colorectal and ovarian carcinoma recurrences. Early observations

1 reference

12 December 2020

Elevation of facilitated glucose-transporter messenger RNA in human hepatocellular carcinoma

1 reference

12 December 2020

Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.

1 reference

12 December 2020

[Positron emission tomography (PET) in the preoperative evaluation of cervical lymph node metastasis of ORL cancer]

1 reference

12 December 2020

In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck

1 reference

12 December 2020

An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer

1 reference

12 December 2020

Metastases in carcinoma; analysis of 1000 autopsied cases

1 reference

12 December 2020

Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma

1 reference

12 December 2020

Clinical perspective of human colorectal cancer metastasis

1 reference

12 December 2020

Effects of hyperglycemia on FDG uptake in human brain and glioma.

1 reference

12 December 2020

Preoperative identification of benign versus malignant parotid masses: a comparative study including positron emission tomography

1 reference

12 December 2020

Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for larynx cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01249629

1 reference

release_62umhmitlfatnbthhl6uarturu

28 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/62umhmitlfatnbthhl6uarturu

24 November 2022

mapped directly with Wikidata item

1 reference